Recombinant Anti-VAP-1 (Clone TK8-14)
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
Recombinant Anti-VAP-1 (Clone TK8-14)
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
Recombinant Anti-VAP-1 (Clone 2D10)
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
Recombinant Anti-VAP-1 (Clone TK8-14)
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
Recombinant Anti-VAP-1 (Clone 2D10)
| Applications | ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
Recombinant Anti-Insulin Receptor alpha (Clone 83-14)
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Bovine, Pig, Sheep |
Recombinant Anti-EGFR (Clone 528)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
Anti-HTRA1 Reference Antibody (Galegenimab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab duocarmazine)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-4Ra / CD124 Reference Antibody (dupilumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus |
Anti-CD19 Reference Antibody (Loncastuximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-IL-13Ra1 / CD213a1 Reference Antibody (MK-6105)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-IL-22Ra Reference Antibody (ARGX-112)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Macaque, Cynomolgus |
Anti-CD19 Reference Antibody (coltuximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-CD19 Reference Antibody (denintuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD19 Reference Antibody (inebilizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |